The role of neoadjuvant chemotherapy in advanced ovarian cancer: The right treatment to the right patient - Ensuring optimal outcomes in advanced ovarian cancer

被引：2
|
作者：
Armbrust, Robert [1 ]
Fotopoulou, Christina [1 ,2 ,3 ]
Sehouli, Jalid [1 ]
机构：
[1] Charite Univ Med Berlin, Virchow Campus Clin, Ctr Oncol Surg, Dept Gynecol, Augustenburger Pl, D-10117 Berlin, Germany
[2] Imperial Coll London, Fac Med, Dept Surg & Canc, London, England
[3] Hammersmith Hosp, London, England
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2024年 / 131卷 / 11期
关键词：
D O I：
10.1111/1471-0528.17707
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：1573 / 1574
页数：2
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy in advanced stage epithelial ovarian cancer
    Kartsiounis, Christos
    Mitsakis, Ioannis
    Boutis, Anastasios
    Triantafillidis, Efstathios
    Evangelinos, Dimitrios
    Andreadis, Charalambos
    Kellartzis, Argirios
    ANNALS OF ONCOLOGY, 2006, 17 : 175 - 175
  • [22] Neoadjuvant Chemotherapy or Primary Surgery in Advanced Ovarian Cancer
    Chua, Terence C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (24): : 2371 - 2371
  • [23] Clinical outcome of neoadjuvant chemotherapy for advanced ovarian cancer
    Kessous, Roy
    Laskov, Ido
    Abitbol, Jeremie
    Bitharas, Joanna
    Yasmeen, Amber
    Salvador, Shannon
    Lau, Susie
    Gotlieb, Walter H.
    GYNECOLOGIC ONCOLOGY, 2017, 144 (03) : 474 - 479
  • [24] Use of neoadjuvant chemotherapy in advanced ovarian cancer.
    Meyer, Larissa
    Cronin, Angel
    Sun, Charlotte C.
    Bookman, Michael A.
    Burger, Robert Allen
    Cristea, Mihaela C.
    Griggs, Jennifer J.
    Levenback, Charles F.
    Mantia-Smaldone, Gina
    Matulonis, Ursula
    Niland, Joyce C.
    O'Malley, David M.
    Wright, Alexi A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [25] Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer
    Thrall, Melissa M.
    Gray, Heidi J.
    Symons, Rebecca Gaston
    Weiss, Noel S.
    Flum, David R.
    Goff, Barbara A.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (03) : 461 - 466
  • [26] A STUDY OF OPTIMAL ADMINISTRATION CYCLE OF NEOADJUVANT CHEMOTHERAPY FOR ADVANCED OVARIAN CANCER.
    Ukita, M.
    Fujishima, R.
    Miyagawa, C.
    Aoki, M.
    Murakami, K.
    Takaya, H.
    Kotani, Y.
    Shimaoka, M.
    Tobiume, T.
    Nakai, H.
    Tsuji, I.
    Suzuki, A.
    Mandai, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1521 - 1521
  • [27] RADIOLOGICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY AS INDICATOR OF OPTIMAL CYTOREDUCTION IN ADVANCED OVARIAN CANCER
    Maricic, S.
    Mandic, A.
    Bunovic, N. Prvulovic
    Stojanovic, S.
    Stojic, I.
    Stanulovic, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A117 - A117
  • [28] THE ROLE OF CHEMOTHERAPY IN THE MANAGEMENT OF ADVANCED OVARIAN CANCER
    NASR, ALA
    CANCER CHEMOTHERAPY REPORTS, 1961, (13): : 185 - 191
  • [29] The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer
    Skof, Erik
    Merlo, Sebastjan
    Pilko, Gasper
    Kobal, Borut
    RADIOLOGY AND ONCOLOGY, 2016, 50 (03) : 341 - 346
  • [30] THE ROLE OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH ADVANCED (STAGE IIIC) EPITHELIAL OVARIAN CANCER
    Skof, E.
    Cerar, O.
    Bebar, S.
    Djurisic, A.
    Merlo, S.
    Vakselj, A.
    Kobal, B.
    Cvjeticanin, B.
    Barbic, M.
    Meglic, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1494 - 1494
12345